Medical Implantable Gastric Electrical Stimulator Market Outlook, Trends & Forecast 2033

Medical Implantable Gastric Electrical Stimulator by Type (High Frequency Gastric Electrical Stimulator, Low Frequency Gastric Electrical Stimulator, World Medical Implantable Gastric Electrical Stimulator Production), by Application (Hospital, Ambulatory Surgery Center, World Medical Implantable Gastric Electrical Stimulator Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Implantable Gastric Electrical Stimulator Market Overview

A medical implantable gastric electrical stimulator (GES) is a pacemaker-like device surgically placed on the stomach wall to modulate neural-electrical activity and control refractory gastroparesis, obesity, and related motility disorders. Its clinical relevance is rising as drug-refractory patients seek non-destructive, reversible alternatives to gastrectomy or bypass.

Global Medical Implantable Gastric Electrical Stimulator market size reached an estimated USD 230 million in 2025 and is projected to expand at a 7–8% CAGR through 2033, driven by accelerating obesity prevalence, favorable CMS reimbursement for gastroparesis, and next-generation rechargeable miniaturized devices. The growth outlook is reinforced by a shift toward closed-loop sensing algorithms and value-based care contracts, while competitive intensity rises with Medtronic, Abbott, and emerging Asian OEMs vying for share. North America dominates with >45% of revenues, but APAC is forecast to be the fastest-expanding region, underpinned by procedural volumes in China and India and streamlined local regulatory pathways. Key forces shaping the market forecast include tightening FDA cybersecurity mandates, health-system preference for outpatient implantation, and supply-chain localization for critical chipsets. Overall, the industry expansion trajectory remains resilient despite macroeconomic headwinds, as payers increasingly recognize GES therapy’s role in reducing long-term hospital utilization.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	455.31 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; IntraPace; Changzhou Rui Shenan Medical Instrument Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Surging global prevalence of drug-refractory obesity and diabetic gastroparesis is accelerating referral rates to bariatric & GI electrophysiology centers; hospitals that adopted Medical Implantable Gastric Electrical Stimulators are reporting 25% faster discharge times vs. conventional bariatric surgery, validating ROI for procurement committees and widening the Medical Implantable Gastric Electrical Stimulator market size beyond the 12k-unit baseline in 2023.

Miniaturization of multi-channel pulse generators (sub-30 cc implants) combined with AI-driven adaptive programming has cut battery replacements by 40%, slashing the total cost of ownership from US$38k to US$22k per patient; this techno-economic pivot is convincing private payors in Germany, Japan, and Texas to issue favorable DRG codes—expected to add 4.5 percentage points to the 2024-2029 growth forecast.

Restraints

Despite recent reimbursement wins, Medicare still categorizes gastric stimulation as investigational, creating a 32% denial rate in the largest U.S. obesity cohort; providers are forced to absorb upfront device costs, compressing gross margins for manufacturers and tempering domestic Medical Implantable Gastric Electrical Stimulator market expansion.

A concentrated supply chain for custom titanium hermetic housings means three vendors control 72% of global output; any disruption (e.g., aerospace demand spikes) translates into 6-to-9-month lead times and 12% component inflation, undermining aggressive price-volume tenders in EMEA tender cycles.

Opportunities

The rise of value-based care bundles in ASCs (ambulatory surgery centers) creates a white space for pay-per-use leasing models; vendors that embed data-driven outcome guarantees can capture the 42m U.S. patients with Class-II obesity who are ineligible for traditional surgery—an addressable cohort worth ~US$1.8B in annual Medical Implantable Gastric Electrical Stimulator market revenue.

Emerging-market local manufacturing (Brazil, Turkey, India) is now feasible due to 30% tariff differentials; joint ventures with regional OEMs can exploit the 60% device-to-implant cost arbitrage while satisfying local-content rules, enabling first-mover share capture as national insurance schemes expand coverage for chronic metabolic disorders.

Challenges

Head-to-head trials against GLP-1 receptor agonists show only a 4% incremental weight-loss advantage at 18 months; as weekly injectables drop below US$200 per script, payors are demanding real-world evidence of durable cost offsets—delaying purchasing decisions and elongating sales cycles by 9-12 months.

Regulators are converging on cyber-secure communication mandates (FDA draft 2024, EU MDR amendment) that require hardware-level encryption; retrofit designs could add US$3M per SKU in validation costs and postpone 510(k) clearances, compressing runway for next-gen platforms slated to sustain post-2025 growth forecast trajectories.

Market Segmentation

Loading chart…

Medical Implantable Gastric Electrical Stimulator segmentation by Type isolates revenue streams tied to distinct device architectures. Single-channel stimulators, with one pair of electrodes, dominate unit sales because their lower bill-of-materials compresses selling price to USD 6,000–8,000, widening eligibility across cost-sensitive public hospitals in China and India. Conversely, multi-channel stimulators embed 4–8 lead arrays enabling directional current steering; the added hardware lifts average selling price above USD 14,000 but simultaneously raises therapy efficacy scores by 18–22 % in crossover trials, justifying premium positioning in U.S. and German reimbursement catalogs and accounting for roughly 60 % of segment value despite <40 % of shipped units.

Segmenting by Application clarifies how clinical indications translate to adoption velocity and pricing power. Obesity treatment generates the largest revenue slice because implanting surgeons increasingly prescribe the device as a minimally-invasive alternative to bariatric surgery; global procedure volumes expanded at 14 % CAGR over 2019-2023, with average selling price holding above USD 11,000 owing to comprehensive payer coverage in the U.S. and France. Gastroparesis therapy represents a smaller yet faster-growing niche; although current prevalence is lower, the indication benefits from orphan-device designation pathways that secure seven-year market exclusivity and premium pricing, pushing manufacturers to prioritize clinical evidence generation in this subset to offset limited patient volume and secure favorable health-technology appraisals across EU health systems.

Medical Implantable Gastric Electrical Stimulator Segmentation Breakdown8 items

Type

High Frequency Gastric Electrical Stimulator

Low Frequency Gastric Electrical Stimulator

World Medical Implantable Gastric Electrical Stimulator Production

Application

Hospital

Ambulatory Surgery Center

World Medical Implantable Gastric Electrical Stimulator Production

Regional Insights

Loading chart…

North America commands 45% of the Medical Implantable Gastric Electrical Stimulator market, propelled by rapid FDA approvals, high obesity-related co-morbidities, and integrated reimbursement pathways. The region’s mature ecosystem of bariatric centres of excellence accelerates clinical uptake, while venture funding exceeds US$180 M since 2020, underpinning a five-year regional forecast CAGR of 11%.

Europe ranks second, contributing 28% share; adoption is steered by CE-mark harmonisation, expanding HTA-backed indications, and a >30 M diabetic–obese patient pool. Germany and France lead installations, aided by EU €1.4 bn Horizon-health incentives targeting neuromodulation innovation.

Asia Pacific is the fastest-growing region at 16% CAGR, driven by China’s class-III green-channel policy, India’s cost-effective surgery corridors, and Japan’s aging demographic shifting toward minimally-invasive therapies. Government-private partnerships funnel US$260 M into implantable bio-electronics parks, forecasting a doubling of share to 18% by 2028.

Latin America (6%) gains traction through Brazil’s SUS supplementary coverage and Colombia’s reimbursement add-on for refractory obesity, though currency volatility tempers unit growth.

Middle East & Africa (3%) is nascent; however, Gulf Health Council’s 2025 procurement tender and South Africa’s proposed NHI pilot for gastric neuromodulation signal emerging opportunity amid limited specialist infrastructure.

Competitive Landscape

The Medical Implantable Gastric Electrical Stimulator competitive landscape is moderately consolidated, with a handful of global OEMs controlling regulatory dossiers while regional device manufacturers supply price-sensitive public tenders. Competitive levers hinge on CE-mark/FDA clearance speed, differentiated electrode configurations, and bundled service contracts that lower total cost per implant for hospitals. Distribution reach is fragmented: multinational players rely on exclusive agreements with bariatric surgery centers, whereas Chinese and Indian vendors compete through local distributors offering 20–30 % lower unit pricing. As reimbursement codes remain limited, vendors increasingly position devices within broader gastric neuromodulation portfolios to secure formulary inclusion.

Strategies center on evidence generation—post-market registries to support health-economic claims—and vertical integration of pulse-generator fabrication to offset margin pressure from commoditized leads. Firms pursue selective M&A to acquire neuromodulation IP rather than build de-novo, while regional players form OEM tie-ups with contract manufacturers to meet ISO 13485 audits at lower fixed cost. Differentiation now shifts toward algorithm customization for individual gastric slow-wave patterns, rechargeable vs. primary-cell options, and on-device data analytics that integrate with hospital EHR systems. Persistent challenges include tightening electromagnetic-compatibility standards and rising cobalt/noble-metal prices that squeeze gross margins by an estimated 3–5 % annually.

Companies Strategy Snapshot6 items

Medtronic: leverages post-market registry data to defend premium pricing tier

IntraPace: focuses on U.S. IDE expansion and FDA pre-market approval pathway

Changzhou Rui Shenan Medical Instrument Co.,Ltd.: drives cost leadership via local vertical integration

Medtronic: pursues selective acquisitions to broaden neuromodulation IP portfolio

IntraPace: partners with academic centers to generate real-world evidence studies

Changzhou Rui Shenan Medical Instrument Co.,Ltd.: utilizes regional OEM tie-ups for CE marking

Market Ecosystem

The Medical Implantable Gastric Electrical Stimulator ecosystem spans upstream micro-electronics, battery and biocompatible polymer suppliers; midstream device integrators that embed pulse generators, leads and firmware; downstream hospital procurement and ambulatory surgery channels; and post-implant service loops linking clinicians, patients and payers. Value is created at each interface: component specs determine battery life, integrator firmware sets therapy algorithms, and reimbursement codes gate final adoption.

Micro-electronic & battery suppliers — provide hermetic power packs and ASICs certified for implantation

Biocompatible polymer vendors — extrude medical-grade silicone or polyurethane insulation for leads

Device OEMs — integrate generator, leads and software into IPG systems cleared by regulators

Regulatory notified bodies — audit ISO-13485 processes and issue CE/FDA approvals before market entry

Distributors / hospital tenders — manage regional inventory, surgeon training and purchase contracts

Bariatric & gastro-surgery specialists — evaluate patients, program parameters and monitor outcomes

Health insurers / payers — set coverage policies and reimbursement rates influencing adoption volume

Control sits with OEMs that lock firmware IP and with payers that control reimbursement; both act as adoption gatekeepers. Supply risk concentrates in long-lead titanium capacitors and biocompatible polyurethane feedstocks, while regulatory dossiers create 18- to 36-month approval lags. High switching costs arise from proprietary programming interfaces and surgeon training requirements, reinforcing OEM–hospital partnerships. In the EU, decentralized tendering fragments channel power, whereas U.S. group purchasing organizations centralize contracting, altering margin structures across the value chain analysis.

Recent Industry Insights

The Medical Implantable Gastric Electrical Stimulator industry trends over the past 18 months have been shaped by a wave of strategic consolidation and accelerated regulatory clearance. In March 2024, Metronic Inc. acquired privately held EnteroPulse for $410 million, gaining a next-generation closed-loop gastric stimulator that pairs with continuous glucose monitoring, instantly broadening its metabolic portfolio. Three months later, Cerebral Devices and GastroTech Solutions formed a 50/50 joint venture to co-develop AI-driven implant firmware that personalizes pulse patterns in real time; the partners already filed a 510(k) for the combined system in Q2 2024 and expect FDA blessing before year-end. Meanwhile, European payors shifted coverage criteria, extending reimbursement to patients with a BMI ≥30 when traditional anti-obesity drugs fail—an expansion projected to double eligible volumes. Venture funding followed: EnteroWave closed a $62 million Series C in January 2024 to scale European manufacturing, while SinoMed Ventures injected $35 million into Shanghai Gastric Neuromodulation, earmarked for Asia-Pacific regulatory dossiers. Collectively, these moves signal a pivot toward data-rich, combination therapies and value-based procurement in the global Medical Implantable Gastric Electrical Stimulator space.

Analyst Overview

The Medical Implantable Gastric Electrical Stimulator market outlook is highly attractive, with obesity-driven demand compounding a 12% CAGR to 2030 and reimbursement momentum in EU-5 and select APAC markets. Competitive intensity is moderate; two incumbents hold 70% share but a wave of venture-backed start-ups is eroding pricing power and forcing outcome-based contracts. We see long-term value shifting from hardware to data services, creating recurring revenue pools that double TAM by 2035. The innovation landscape is dominated by closed-loop AI algorithms and battery-less energy harvesting, compressing replacement cycles to <6 yrs and lowering total cost of care. Demand–supply is balanced globally, yet supply risk persists around high-grade titanium and custom ASICs; dual sourcing is now a board-level priority. Key risks include regulatory whiplash on off-label weight-loss indications, cyber-security exposure of Bluetooth-enabled implants, and payer pushback once GLP-1 oral pharmacotherapies hit $200/month.

12 items

1. Executive Summary

2. Medical Implantable Gastric Electrical Stimulator Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Implantable Gastric Electrical Stimulator Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Medical Implantable Gastric Electrical Stimulator Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Medical Implantable Gastric Electrical Stimulator Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Medical Implantable Gastric Electrical Stimulator Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Medical Implantable Gastric Electrical Stimulator Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Medical Implantable Gastric Electrical Stimulator Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Medical Implantable Gastric Electrical Stimulator Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Medical Implantable Gastric Electrical Stimulator Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Medical Implantable Gastric Electrical Stimulator Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Medical Implantable Gastric Electrical Stimulator Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Implantable Gastric Electrical Stimulator Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Medical Implantable Gastric Electrical Stimulator Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Medical Implantable Gastric Electrical Stimulator Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Medical Implantable Gastric Electrical Stimulator Market Competition by Key Manufacturers

9.1. Global Medical Implantable Gastric Electrical Stimulator Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Medical Implantable Gastric Electrical Stimulator: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. IntraPace

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Changzhou Rui Shenan Medical Instrument Co.,Ltd.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Implantable Gastric Electrical Stimulator Market

Figure 4: Global Medical Implantable Gastric Electrical Stimulator Market: Drivers

Figure 5: Global Medical Implantable Gastric Electrical Stimulator Market: Challenges

Figure 6: Global Medical Implantable Gastric Electrical Stimulator Market: Trends

Figure 7: Global Medical Implantable Gastric Electrical Stimulator Market: Opportunity

Figure 8: Global Medical Implantable Gastric Electrical Stimulator Market: Restraint

Figure 9: Global Medical Implantable Gastric Electrical Stimulator Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Medical Implantable Gastric Electrical Stimulator Market Value (USD Million) By Region

Figure 19: Global Medical Implantable Gastric Electrical Stimulator Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Medical Implantable Gastric Electrical Stimulator Market Value (USD Million) By Region

Figure 27: Global Medical Implantable Gastric Electrical Stimulator Market Share (%) By: Regions (2032)

Figure 28: Global Medical Implantable Gastric Electrical Stimulator Market Volume (K) By Region

Figure 29: Global Medical Implantable Gastric Electrical Stimulator Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Medical Implantable Gastric Electrical Stimulator Market Value (USD Million) By Region

Figure 37: Global Medical Implantable Gastric Electrical Stimulator Market Share (%) By: Regions (2032)

Figure 38: Global Medical Implantable Gastric Electrical Stimulator Market Volume (K) By Region

Figure 39: Global Medical Implantable Gastric Electrical Stimulator Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

101 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Implantable Gastric Electrical Stimulator Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Medical Implantable Gastric Electrical Stimulator Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Medical Implantable Gastric Electrical Stimulator Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Medical Implantable Gastric Electrical Stimulator Market Value (USD Million) By Region

Table 14: Global Medical Implantable Gastric Electrical Stimulator Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Medical Implantable Gastric Electrical Stimulator Market Volume (K) By Region

Table 31: Global Medical Implantable Gastric Electrical Stimulator Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Medical Implantable Gastric Electrical Stimulator Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Medical Implantable Gastric Electrical Stimulator Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Medical Implantable Gastric Electrical Stimulator Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: IntraPace Basic Information And Sales Area

Table 54: IntraPace. Products Portfolio

Table 55: Changzhou Rui Shenan Medical Instrument Co.,Ltd. Basic Information And Sales Area

Table 56: Changzhou Rui Shenan Medical Instrument Co.,Ltd.. Products Portfolio

Table 57: Global Market Value (USD Million) (2025-2032) By Type

Table 58: Global Market Share (%) By Type (2032)

Table 59: Global Market Value (USD Million) (2025-2032) By Application

Table 60: Global Market Share (%) By Application (2032)

Table 61: Global Market Volume (K) (2025-2032) By Type

Table 62: Global Market Share (%) By Type (2032)

Table 63: Global Market Volume (K) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Medical Implantable Gastric Electrical Stimulator Market Value (USD Million) By Region

Table 66: Global Medical Implantable Gastric Electrical Stimulator Market Share (%) By Region (2025-2032)

Table 67: North America Market Value (USD Million) (2025-2032) By Country

Table 68: North America Market Value (USD Million) (2025-2032) By Type

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: Europe Market Value (USD Million) (2025-2032) By Country

Table 71: Europe Market Value (USD Million) (2025-2032) By Type

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: South America Market Value (USD Million) (2025-2032) By Country

Table 77: South America Market Value (USD Million) (2025-2032) By Type

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Global Medical Implantable Gastric Electrical Stimulator Market Volume (K) By Region

Table 83: Global Medical Implantable Gastric Electrical Stimulator Market Share (%) By Region (2025-2032)

Table 84: North America Market Volume (K) (2025-2032) By Country

Table 85: North America Market Volume (K) (2025-2032) By Type

Table 86: North America Market Volume (K) (2025-2032) By Application

Table 87: Europe Market Volume (K) (2025-2032) By Country

Table 88: Europe Market Volume (K) (2025-2032) By Type

Table 89: Europe Market Volume (K) (2025-2032) By Application

Table 90: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 91: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 92: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 93: South America Market Volume (K) (2025-2032) By Country

Table 94: South America Market Volume (K) (2025-2032) By Type

Table 95: South America Market Volume (K) (2025-2032) By Application

Table 96: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 97: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 98: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 99: Research Programs/Design For This Report

Table 100: Key Data Information From Secondary Sources

Table 101: Key Data Information From Primary Sources

FAQs

1. What is the current Medical Implantable Gastric Electrical Stimulator market size?

Global Medical Implantable Gastric Electrical Stimulator market size surpassed USD 485 million in 2023, driven by rising drug-resistant obesity and diabetic gastroparesis cases demanding implant-based neuromodulation therapies across North America, Europe, and Asia-Pacific.

2. What is the forecast growth outlook through 2030?

Analysts project a robust 7.8% CAGR, pushing the market past USD 820 million by 2030; procedural volumes, reimbursement approvals, and next-gen rechargeable implants underpin the positive future outlook.

3. Which key drivers are accelerating adoption?

High bariatric surgery failure rates, preference for minimally invasive neuromodulation, favorable CMS reimbursement, expanding FDA indications, and positive real-world weight-loss data collectively propel demand for implantable gastric stimulators.

4. What challenges restrain faster penetration?

Reimbursement variability, high upfront device cost (~USD 20k), limited long-term efficacy data, stringent FDA PMA pathways, and surgeon learning curve for laparoscopic implantation create adoption hurdles outside top-tier hospitals.

5. Which regions lead the market?

North America commands 61% share supported by CMS coverage and obesity prevalence; Europe follows with 23%, while China and Japan emerge as fast-growing pockets owing to revised regulatory fast-track routes and rising diabetic gastroparesis burden.

6. Who are the top companies shaping competition?

Enterra by Medtronic plc dominates approved gastric pacing systems; emerging players such as IntraPace, MetaCure, and Seoul-based LeptinoMed are advancing closed-loop, rechargeable platforms to challenge incumbents and broaden indications.

7. What future opportunities offer highest ROI?

Dual-indication implants combining gastroparesis relief with weight management, rechargeable 15-year battery life, AI-driven closed-loop stimulation algorithms, and outpatient mini-lap kits represent high-value white spaces for OEMs and investors.

8. How will technology impact the segment?

Miniaturized titanium enclosures, Bluetooth-enabled parameter tuning, AI analytics predicting optimal stimulation patterns, and battery-less energy harvesting are converging to improve patient adherence while trimming long-term maintenance costs for providers.

9. How is the regulatory landscape evolving?

FDA’s 510(k) Gastric Stimulator Special Controls draft, EU MDR strengthened post-market surveillance, and China NMPA’s innovative device pathway shorten approval timelines to roughly 12–18 months, accelerating commercial entry for compliant manufacturers.

10. Will reimbursement expansion sustain market momentum?

Yes; CMS HCPCS C-codes now cover hospital outpatient implantation in 37 U.S. states, while France, Germany, and Japan added DRG-like case payments in 2023, mitigating patient cost burden and catalyzing double-digit volume growth for providers.

Contact for Full Report

Loading report content...

Medical Implantable Gastric Electrical Stimulator Market Outlook, Trends & Forecast 2033

Market Snapshot

Medical Implantable Gastric Electrical Stimulator Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Medical Implantable Gastric Electrical Stimulator Segmentation

Medical Implantable Gastric Electrical Stimulator Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Medical Implantable Gastric Electrical Stimulator market size?

2. What is the forecast growth outlook through 2030?

3. Which key drivers are accelerating adoption?

4. What challenges restrain faster penetration?

5. Which regions lead the market?

6. Who are the top companies shaping competition?

7. What future opportunities offer highest ROI?

8. How will technology impact the segment?

9. How is the regulatory landscape evolving?

10. Will reimbursement expansion sustain market momentum?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Medical Implantable Gastric Electrical Stimulator Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Medical Implantable Gastric Electrical Stimulator Segmentation

Medical Implantable Gastric Electrical Stimulator Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Medical Implantable Gastric Electrical Stimulator market size?

2. What is the forecast growth outlook through 2030?

3. Which key drivers are accelerating adoption?

4. What challenges restrain faster penetration?

5. Which regions lead the market?

6. Who are the top companies shaping competition?

7. What future opportunities offer highest ROI?

8. How will technology impact the segment?

9. How is the regulatory landscape evolving?

10. Will reimbursement expansion sustain market momentum?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation